Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology
Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

NCT02140736

CompletedN/A

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer

Conditions: Chemotherapy-induced Symptomatic Anemia, Solid Tumors, Malignant Hemopathies, Lymphomas, Myelomas

Interventions: Epoetin biosimilar

Countries: France

The main aim of this study is to observe correction of the hemoglobin level in the patients under chemotherapy, treated with epoetin alfa biosimilar and presenting with a solid tumor or a lymphoma or a myeloma.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients of more than 18 years of age
* Patients presenting with anemia following chemotherapy
* Patients suffer from solid tumours, malignant hemopathies, lymphomas or myelomas and presenting with anemia following chemotherapy

  \-- The patients may be included regardless of their chemotherapy cycle (from the first cycle until the last cycle)
* Patients eligible for epoetin alfa biosimilar treatment

Exclusion Criteria:

* Patients are not receiving chemotherapy
* Patients already included in an epoetin zeta trial
* Patients presenting with a contraindication to epoetin zeta
* Patients presenting with hypersensitivity to the active principle or any of the excipients
* Patient with erythroblastopenia or acquired pure red cell aplasia (APRCA)
* Patient with uncontrollable arterial hypertension
* Patients who cannot receive adequate prophylaxis by antithrombotic agents
Locations (172)
  • Agen, France
  • Aix-en-Provence, France
  • Aix-en-Provence, France
  • Aix-en-Provence, France
  • Ajaccio, France
  • Albi, France
  • Amboise, France
  • Amilly, France
  • Annecy, France
  • Antibes, France
  • Armentières, France
  • Arras, France
  • Arras, France
  • Aulnay-sous-Bois, France
  • Avignon, France
  • Avignon, France
  • Bayonne, France
  • Beauvais, France
  • Besançon, France
  • Beuvry, France
  • Béthune, France
  • Béziers, France
  • Blois, France
  • Bois-Guillaume, France
  • Bordeaux, France
  • Bordeaux, France
  • Bordeaux, France
  • Boulogne-sur-Mer, France
  • Brest, France
  • Brest, France
  • + 142 more on CT.gov